(株)免疫生物研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証GRT | 医薬品 | 4570/E00986 | Immuno-Biological Laboratories Co.,Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2014/10/24 | 日証協 | 223,540株 | -1.24% | 200株 | -94.01% | 199,859株 | -0.15% | 600株 | -91.18% |
2014/10/17 | 日証協 | 226,340株 | +0.35% | 3,340株 | +108.75% | 200,159株 | +3.52% | 6,800株 | +223.81% |
2014/10/10 | 日証協 | 225,540株 | -1.91% | 1,600株 | -84.31% | 193,359株 | -0.62% | 2,100株 | -88.01% |
2014/10/03 | 日証協 | 229,940株 | +2.63% | 10,200株 | +500% | 194,559株 | -1.02% | 17,511株 | +356.02% |
2014/09/26 | 日証協 | 224,040株 | -0.44% | 1,700株 | -70.69% | 196,559株 | -0.71% | 3,840株 | +22.29% |
2014/09/19 | 日証協 | 225,040株 | +2.52% | 5,800株 | -81.76% | 197,959株 | +1.04% | 3,140株 | -80.62% |
2014/09/12 | 日証協 | 219,500株 | +7.7% | 31,800株 | +120.83% | 195,919株 | +2.89% | 16,200株 | -15.62% |
2014/09/05 | 日証協 | 203,800株 | -3% | 14,400株 | +453.85% | 190,419株 | -0.84% | 19,200株 | +214.75% |
2014/08/29 | 日証協 | 210,100株 | -3.76% | 2,600株 | 0% | 192,029株 | -0.72% | 6,100株 | +190.48% |
2014/08/22 | 日証協 | 218,300株 | 0% | 0株 | -100% | 193,429株 | +0.47% | 2,100株 | -25% |
2014/08/15 | 日証協 | 218,300株 | +2.06% | 4,400株 | 0% | 192,529株 | +2.12% | 2,800株 | +33.33% |
2014/08/08 | 日証協 | 213,900株 | -2.46% | 0株 | -100% | 188,529株 | -0.79% | 2,100株 | +5% |
2014/08/01 | 日証協 | 219,300株 | -4.03% | 7,400株 | +94.74% | 190,029株 | -2.76% | 2,000株 | -23.08% |
2014/07/25 | 日証協 | 228,500株 | +2.42% | 3,800株 | -62.75% | 195,429株 | +2.2% | 2,600株 | -53.57% |
2014/07/18 | 日証協 | 223,100株 | +4.2% | 10,200株 | +466.67% | 191,229株 | +2.68% | 5,600株 | +51.35% |
2014/07/11 | 日証協 | 214,100株 | 0% | 1,800株 | -57.14% | 186,229株 | -2.15% | 3,700株 | -33.93% |
2014/07/04 | 日証協 | 214,100株 | +4.59% | 4,200株 | -67.44% | 190,329株 | +4.05% | 5,600株 | -22.22% |
2014/06/27 | 日証協 | 204,700株 | -2.34% | 12,900株 | +1333.33% | 182,929株 | +0.22% | 7,200株 | +75.61% |
2014/06/20 | 日証協 | 209,600株 | 0% | 900株 | +80% | 182,529株 | +0.5% | 4,100株 | +57.69% |
※株式分割は考慮していませんのでご注意ください。